Observational Study on Sars CoV2 Vaccinations in Patients with MS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025221

Enrollment

1000

Registered

2021-05-03

Start date

2021-05-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

En: MedDRA - 10084268 En: MedDRA - 10084465 G35 U07.1

Interventions

Group 1: Patients diagnosed with multiple sclerosis and at least on vaccination that are followed up via an online survey.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Multiple Sclerosis Sars CoV2 Vaccination

Exclusion criteria

Exclusion criteria: Missing abillity to consent

Design outcomes

Primary

Measure	Time frame
Online survey to capture the occourence of vaccination reactions in relation to basic data on the MS. Surveys at time of 1st vaccination and at month 3, 6, and if needed 12.	—

Secondary

Measure	Time frame
Relation between vaccination reactions and current / prior disease modifying therapy Annualised Relapse rate changes and changes in MS progression in relation to the vaccination	—

Countries

Germany

Contacts

Public ContactNiklas Frahm

MS Forschungs- und Projektentwicklungs-gGmbH

frahm@msregister.de0511 44 45 99 55

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026